Trademark Attorney / Law Firm
Kristofer Elbing – Trademark Portfolio
Kristofer Elbing specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 6 of 11 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 3 other Nice Classification classes. Filing activity spans from 2020 to 2026. Currently, 1 trademark is registered and 8 are pending.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Kristofer Elbing's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has Kristofer Elbing filed?
Kristofer Elbing has filed 11 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 8 pending, 2 abandoned.
What trademark classes does Kristofer Elbing specialize in?
Kristofer Elbing has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
How long has Kristofer Elbing been filing trademarks?
Kristofer Elbing's trademark filing history with the USPTO spans from 2020 to 2026, covering 6 years of trademark practice. During this period, Kristofer Elbing has handled 11 trademark applications.
What is Kristofer Elbing's trademark registration success rate?
Kristofer Elbing has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 8 applications are pending review.